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Abstract. Dietary supplementation with n-3 fatty acids 
from fish oil alleviates inflammation in various chronic 
inflammatory disease states. Reductions in the produc­
tion of pro-inflammatory cytokines interleukin 1 ¡3 (IL- 
1/3), tumour necrosis factor alpha (TNF-a), and inter­
leukin 6 (IL-6) have been seen in humans after short-term 
/?.-3 fatty acid supplementation. We investigated long­
term effects of dietary n-3 fatty acids on circulating 
cytokine concentrations and on ex vivo stimulated 
whole-blood production of IL-1/3, TNF-a and interleukin
1 receptor antagonist (IL-IRa), the naturally occurring 
antagonist of IL-1. A total of 58 monks with a mean age 
of 56 years were randomized into four groups and their 
diets were supplemented with 0, 3, 6, or 9 g of fish oil, 
providing 0, 1*06, 2-13 or 3-19g of n-3 fatty acids per 
day. Subjects received equal amounts of saturated fatty 
acids, vitamin E and cholesterol. Compliance was excel­
lent and erythrocyte fatty acid profiles closely reflected 
the amounts of n-3 fatty acids ingested. In the group 
receiving 9 g of fish oil per day, no influence of n-3 fatty 
acids on circulating cytokine concentrations was 
observed relative to placebo. Endotoxin-stimulated 
whole-blood cytokine production was measured at 26 
and 52 weeks after the start and at 4, 8 and 26 weeks after 
cessation of supplementation. In all groups, the production 
of IL-ljS and IL-IRa was higher during supplementation 
than afterwards. However, no differences in cytokine 
production were noted between the placebo group and 
the various treatment groups at any point in time. Our 
results suggest that long-term supplementation of fish oil 
does not affect ex vivo cytokine production in man.
Keywords. Cytokines, fish oils, interleukin 1, interleukin 
6, interleukin-1 receptor, n-3 polyunsaturated fatty acids, 
tumour necrosis factor.
Introduction
n-3 (omega-3) polyunsaturated fatty acids have been
Correspondence: Pierre N. M. Demacker, Department of General 
Internal Medicine, University Hospital Nijmegen, Nijmegen, The 
Netherlands.
investigated for use in the treatment of various inflam­
matory diseases [1]. In patients with rheumatoid arthritis, 
ulcerative colitis and psoriasis, an alleviation of clinical 
symptoms has been noted after ingestion of n-3 fatty 
acids in the form of a fish oil concentrate [2-5]. n-3 fatty 
acids have also been advanced for use in patients with 
burn trauma and in postoperative cancer patients [6-9]. 
The anti-inflammatory effects of n-3 fatty acids have 
originally been attributed to changes in the production of 
prostaglandins and leukotrienes [10-12]. More recently, 
however, reduced production of the pro-inflammatory 
cytokines interleukin la  and j3 (IL-1 a  and j3) and tumour 
necrosis factor alpha (TNF-a) has been emphasized as a 
possible mechanism [13], IL-1 a  and /S, interleukin 6 (IL- 
6), and TNF-a are small proteins that are produced by 
cells of mononuclear phagocytic origin, including 
circulating monocytes and tissue macrophages. These 
cytokines mediate the response of the host to various 
inflammatory stimuli, They induce fever, activation of B 
and T lymphocytes and endothelial cells, synthesis of 
acute-phase proteins by the liver, and many other effects 
that are all part of the acute-phase response [14].
In three studies in healthy volunteers, significant 
reductions in IL-1 and TNF-a: production capacity of 
isolated peripheral blood mononuclear cells were 
observed after 6 weeks to 3 months of dietary fish oil 
supplementation [13,15,16]. However, two controlled 
studies did not find differences in cytokine production 
capacity after 7 weeks and 4 months of dietary fish oil 
supplementation [17,18], Here, we report effects of fish 
oil on cytokine levels in a 1-year placebo-controlled trial.
Subjects and methods
Subjects
Fifty-eight monks from one Trappist and three Benedic­
tine monasteries in The Netherlands participated in the 
study. They were ail in good health and without known 
underlying disease such as diabetes, cancer or coronary 
heart disease. The ages of the subjects ranged from 21 to 
87 years with a mean ±  SD of 56-2 ±  16-5 years. Body 
mass indexes were below 30 kg m f2; systolic and diastolic
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blood pressures were below 160mmHg and 95mmHg 
respectively; concentrations of serum total cholesterol 
were below 7-0 mmol L "1 and triglycerides below
3-0 mmol L“1.
Ten monks were Trappists and thus vegetarians. 
During the study period, the subjects did not take 
medications influencing lipid metabolism or non-steroi- 
dal anti-inflammatory drugs. The study was approved by 
the Ethics Committee of the Department of Human 
Nutrition, and all subjects gave informed consent.
Experimental design
The study consisted of a 2-week baseline period, fol­
lowed by a 1-year treatment and a 6-month follow-up 
period. Within each monastery, the subjects were ran­
domly and blindly divided into four groups, which 
received zero (ft = 14), three (n =15), six (w=15) or 
nine (rc =  14) fish oil capsules per day. In each dosage 
group, the total number of capsules was made up to nine 
by adding nine, six, three or zero placebo capsules 
respectively. Periodically, every subject received three 
bottles with dark-coloured capsules. Depending on the 
dosage group, none, one, two or all three of the bottles 
contained fish oil capsules, whereas the remaining bottles 
contained placebo capsules. At each meal one capsule 
was taken from every bottle. At regular intervals com­
pliance was established by counting the remaining cap­
sules.
A clinical examination including weight, height, 
waist-hip ratio, thigh circumference and blood pressure 
was performed eight times during the trial: on. days -14, 
0 (start of the supplementation), 56, 182, 363 (end of the 
supplementation), 396, 424, and 536. At these times 
blood was also drawn. The conditions used for whole- 
blood ex vivo production of IL-1/3, TNF-a, and IL-IRa 
turned out to have been inappropriate until 26 weeks after 
the start of the dietary supplementation. Thus, these data 
are available only at 26 and 52 weeks of supplementation 
and at 4, 8 and 26 weeks after cessation of the supple­
mentation. In weeks 26 and 52 the subjects recorded their 
habitual food consumption by writing down what they 
had eaten during 3 days. These data were completed by a 
trained dietitian, who interviewed the subjects, weighed 
portion sizes and checked recipes.
All subjects received a diary to record the use of 
medicine, illness, alcohol intake, inadvertent omission 
of capsule intake, and other relevant facts.
Oil supplements
Eicosapentaenoic (EPA)-rich fish oil capsules were a 
kind gift from Labaz (Brussels, Belgium). The placebo 
capsules contained olive oil (Puget, Marseille, France), 
and palm oil (Loders-Kroklaan, Wormerveer, The 
Netherlands). Cholesterol (Merck, Darmstadt, Germany) 
and vitamin E (Organon, Oss, The Netherlands) were 
added. The placebo capsules were also manufactured by 
Labaz. Fatty acids composition and cholesterol content 
of the capsules were determined in our laboratory using
Table 1. Mean fatty acid composition, mean cholesterol and mean 
vitamin E content of fish-oil and placebo capsules
Fish oil 
capsule
Placebo
capsule
Saturated fatty acids (% mass of methylesters) 24 24
Monounsaturated fatty acids 26 65
(% mass of methylesters)
n-3 fatty acids (% mass of methylesters) 37 0-6
n-6 fatty acids (% mass of methylesters) 5 10
Cholesterol (mg/100 g) 115 f 19
Vitamin E (IU/100 g) 63 63
capillary gas-liquid chromatography. The vitamin E 
content was measured by Dr J. Schrijver (CIVO-TNO, 
Zeist, The Netherlands) using a high-performance liquid 
chromatographic (HPLC) method. The composition of 
the fish oil and placebo capsules is shown in Table 1. 
EPA accounted for 72% of all n-3 fatty acids in the fish 
oil. The fish oil and the placebo capsules contained equal 
amounts of saturated fatty acids, vitamin E and choles­
terol. There was a small difference in the concentration 
of ft-6 fatty acids. The n-3 fatty acids of the fish oil 
capsules were replaced by neutral monounsaturated fatty 
acids (largely oleic acid) plus some linoleic acid in the 
placebo capsules. Both capsules contained 1 g of fat; thus 
every subject had 9g of extra fat per day. The daily 
intake of eicosapentaenoic acid (EPA, C2o:5 n-3), doc- 
osahexaenoic acid (DHA, C22:6 «-3), and Ca2:5 «-3 in the 
various treatment groups is shown in Table 2.
«
Measurement o f fatty acids
After an overnight fast, venous blood was di'awn into a 
10-mL vacutainer tube with EDTA as anticoagulant. The 
tubes were centrifuged on the spot at low speed at 4 °C to 
separate red blood cells, The cells were washed twice 
with ice-cold saline, transferred into stoppered plastic 
tubes (Greiner, Nuttingen, Germany), and haemolysed 
by freezing at -80°C for at least 2h. The haemolysates 
were stored at -20°C for a maximum of 7 days. Fatty 
acids of the haemolysates were measured by capillary 
gas chromatography.
Table 2. Daily n-3 fatty acid (gday *) intake in the various treatment 
groups
n-3 fatty 
acid
Low-dose 
fish oil 
group 
(3 g day“ 1)
Medium-dose 
fish oil 
group 
(6 g day“ 1)
High-dose 
fish oil 
group 
(9 g day“ 1)
EPA (C20:5 >z“3) 0-81 1*62 243
(^ 22:5 71-3 0-09 0-18 0-27
DHA (C22:6 n-3) 0-16 0*33 0-49
Total 1-06 243 3-19
EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid.
© 1997 Blackwell Science Ltd, Europetin Journal of Clinical Investigation, 27, 1003-1008
DIETARY FISH OIL SUPPLEMENTATION AND CYTOKINES 1005
Table 3. Concentration of eicosapentaenoic acid (EPA) (Caois «-3) in erythrocyte lipids as a function of duration and 
level of fish oil supplementation. Values are represented as grams of EPA per 100 g fatty acids
Week of experiment* Daily ingestion of fish oil (g)
0 3 6 9
0 0-79 ±  0*21 0-78 ±  0-22 0-74 ±  0*18 0*70 ±  0*22
2 0*85 ±  0-19 1*50 ± 0-20 2*00 ±  0*25 2*49 ±  0-48
4 0-83 ±  0-16 1-83 ±  0*37 2*69 ±  0*31 3-50 ±  0*55
8 0-86 ±  0-30 2-31 ±  0-37 3*41 ±  0-58 4*60 ±  0-86
26 1*12 ±  0-24 3-06 ±  0*38 4*87 ±  0*63 6*16 ±  1-04
52 0*83 ±  0*28 2-82 ± 0-34 4*31 ±  0*92 5-86 ±  1-22
56 0-88 ±  0*28 1-89 ± 0*27 2*77 ±  0*58 3-22 ±  1*06
60 0-78 ± 0-19 1-50 ± 0-24 2*13 ±  0*53 2*52 ±  0-58
78 0-83 ±  0-17 0-86 ±  0*20 0*94 ±  0-30 1-02 ±  0-31
*Fish oil supplementation from week 0 until week 52. From week 56 on, post-supplementation values are represented.
Cytokine measurements
Venous blood was drawn into three 4-mL evacuated y- 
sterilized blood collection tubes (Becton Dickinson, 
Vacutainer Systems, Rutherford, NJ, USA) containing 
6 mg of EDTA. The tubes were filled with blood by 
vacuoaspiration. An aliquot (250 /x1) of aprotinin with an 
activity of 10-000 kallikrein-inactivating units per ML 
(Trasylol, Bayer, Leverkusen, Germany) was added per 
tube. One tube was centrifuged immediately and the 
resultant plasma was drawn off, stored in dry ice, 
transported to the laboratory and stored at -80  °C until 
assay of circulating cytokines. One of the remaining two 
samples was stimulated by the addition of 50 ¡xL of 
endotoxin (lipopolysaccharide, LPS, Escherichia coli 
serotype 055:B5, Sigma, St Louis, MO, USA), concen­
tration 800^gmL-1, final concentration lOjitgmL“1. The 
control sample did not have endotoxin added. The two 
samples were inverted gently to mix and incubated for 
24 h at 25 °C in a circulating water bath. The samples 
were incubated within 5 min after drawing, and incuba­
tion at 25 °C was secured by keeping the samples in a 
portable stove throughout transportation to the labora­
tory. After the incubation, samples were centrifuged at 
1250g for 10 min. For removal of platelets, the resultant 
plasma was spun in an Eppendorf centrifuge at 
13 000rpm for 5 min. Platelet-poor plasma, containing 
the secreted products of endotoxin-stimulated blood 
cells, was drawn off and stored at -80°C until assay of 
cytokines.
IL-ljS, TNF-a and IL-IRa were determined by radio­
immunoassay as described previously [19-21]. The 
intra-assay variability was less than 10%. The detection 
limit of IL-118 was 50 pg mL~\ of TNF-a 50 pg mL" 1 and 
of IL-IRa lOOpgmL-1. Circulating concentrations of IL- 
6 were measured using an enzyme-linked immunosor­
bent assay (ELISA) [22], with a detection limit of 
6 pgmL_1. To avoid experimental fluctuations, one 
batch of LPS and one batch of blood-collecting tubes 
was used throughout the study. All samples of one 
subject were determined in the same series and in each 
series an equal number of samples of each treatment 
group was analysed to avoid bias due to assay variability.
Statistical analysis
Cytokine concentrations of the various diet groups were 
compared using the multivariate rank test according to 
Koziol et aL [23] and Crepeau et aL [24]. This is a non- 
parametric test for the comparison of growth curves, 
which accounts for missing data at certain time points.
Results
Compliance
The interviews taken by the dietitians and the counting of 
the capsules revealed an excellent adherence to the 
experimental protocol throughout the 78 weeks that 
this study lasted. The determinations of fatty acid profiles 
of red blood cells closely reflected the amount of n-3 
fatty acids ingested by the four experimental groups 
(Table 3) [25]. Twenty-six weeks after the cessation of 
the fat supplementation, the fatty acid profiles of the red 
blood cells had returned to pretreatment values. None of 
the subjects experienced adverse effects.
Circulating cytokines
The concentrations of circulating IL-1/3, IL-6, TNF-a 
and IL-IRa were determined only in the groups receiving 
0 and 9g of fish oil per day. As expected, these con­
centrations were low. The concentrations of IL-1/3, TNF- 
and IL-IRa were well above the detection limit of the 
assay in all subjects, but IL-6 was below the detection 
limit in all samples. For the circulating cytokines that 
could be measured, there was no significant difference 
between the two treatment groups at any point in time, 
either in absolute concentrations or in changes relative to 
baseline (Fig. 1). Basal concentrations of circulating 
cytokines were not different between vegetarians and 
non-vegetarians (data not shown).
Ex vivo production of IL-1/3, TNF-a and IL-IRa after 
whole-blood stimulation
In all three dose groups, as well as in the placebo group,
© 1997 Blackwell Science Ltd, European Journal o f Clinical Investigation, 27, 1003-1008
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Figure 1. Circulating concentrations of IL-1/3 (top), TNF-a (middle) 
and IL-IRa (bottom) at various time points before, during, and after 
dietary supplementation with placebo or 3-19 g /?-3 fatty acids per day. 
Results expressed as mean ±  SD.
endotoxin-stimulated secretion of IL-1/3 and IL-IRa was 
significantly higher during oil supplementation than at 8 
and 26 weeks after cessation of capsule intake (Fig. 2). A 
similar trend was observed in the secretion of TNF-a, 
although differences over time were not statistically 
significant. The ex vivo production of IL-1/3, TNF-a 
and IL-IRa was not significantly different between the 
four diet groups at any point in time. The inter-individual 
variations in cytokine production were large. When the 
values obtained at 78 weeks, i.e. 26 weeks after cessation 
of the fat supplementation, are taken as baseline values, 
percentage changes over time can be evaluated. Again, 
these values were not significantly different between the 
various experimental groups at any point in time (data 
not shown). Twenty-six weeks after cessation of the 
dietary supplementation, cytokine production capacity 
was not different between vegetarians and non-vegetar­
ians (data not shown).
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Figure 2. Concentrations of IL-1/3 (top), TNF-a (middle) and IL-IRa 
(bottom) after stimulation of whole blood with lipopolysaccharide 
(lOjigmL-1) for 24 h. Subjects took 0, 1-06, 2*13 or 3-19 g of n-3 
fatty acids per day. For IL-1 Ra, only the groups receiving 0 or 3* 19 g per 
day were analysed. Results expressed as means ±  SD.
Discussion
The findings in this long-term placebo-controlled study 
disagree with the conclusions drawn in some previously 
published studies regarding the effects of dietary fish-oil 
supplementation on ex vivo cytokine production 
[13,15,16,26]. We found no effect of fish oil on the ex 
vivo production of pro-inflammatory cytokines, either 
during supplementation or after cessation of capsule 
intake, relative to placebo. The fluctuations in absolute 
levels in ail groups, including the placebo group, demon­
strate the need for a proper control group in studies of this 
nature, and for a proper analysis that compares the effect 
of fish oil with that of placebo. Statistical testing of 
changes from baseline within the fish oil group may lead 
to the faulty conclusion that fish oil does decrease 
cytokine levels or production [3,27]
In two controlled studies, no effect of dietary fish-oil 
on ex vivo production of IL-1/3 or TNF-a was found at 7 
weeks and 4 months of supplementation [17,18]. Effects 
of n-3 fatty acids that are apparent at 6 weeks may thus
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have disappeared at 26 weeks of dietary fish oil supple­
mentation.
The question remains why the ex vivo production of 
IL-l/3and IL-IRa was higher during the dietary supple­
mentation in both the placebo and the n-3 fatty acids- 
supplemented groups. It is unlikely that the daily inges­
tion of placebo capsules containing 9 g of a mixture of 
olive and palm oil exerts such profound biological effects 
as the fatty acid composition of cholesterylesters, and 
erythrocyte membranes did not change during intake of 
the placebo capsules [25]. A seasonal effect on cytokine 
production capacity is less likely because the measure­
ments after 26 weeks of supplementation (Fig. 2, first 
time point) and after 26 weeks of washout (Fig. 2, final 
time point) were obtained in the same season» 1 year 
apart. Differences with other studies might also be 
explained by the dose of fish oil used [13] or by 
differences in background diet [26]; however, the 
recent study of Schmidt et a l [28] yielded results 
essentially similar to those reported here.
The changes in fatty acid profiles were similar to those 
observed in the other studies mentioned. Therefore, the 
dose of n-3 fatty acids ingested cannot account for the 
lack of an effect on cytokine production.
We have evaluated the cytokine production capacity 
of whole-blood samples, whereas others used in vitro 
stimulation of mononuclear cells that were isolated by 
density gradient centrifugation. The relative simplicity of 
the whole-blood stimulation may render this method less 
prone to experimental biases: manipulation of the cell 
population studied is minimal, stimulation is started 
immediately upon removal of the cells from the circula­
tion and experimental conditions can easily be kept 
constant. Moreover, Nerad et al. [21] have shown a 
good correlation between whole blood IL-i/3 measure­
ment and the method in which mononuclear cells are 
separated by density gradient centrifugation and stimu­
lated ex vivo. Therefore, whole blood stimulation may 
represent a reflection of cytokine production capacity 
that is at least as relevant as a method using cell 
separation techniques.
The concentrations of circulating cytokines were, as 
expected, very low. Higher concentrations can be found 
in severe disease states such as septic shock, burn trauma, 
and after experimental administration of endotoxin [29- 
32]. In rheumatoid arthritis patients, dietary fish oil 
supplementation during 12 weeks resulted in decreased 
circulating concentrations of IL-ljS [33]. Our results 
indicate that dietary fish oil supplementation does not 
affect the low concentrations of circulating cytokines 
that are found under physiological, unstimulated circum­
stances.
In conclusion, in this long-term controlled trial we 
could not confirm that the fish oil induced reduction of ex 
vivo stimulated cytokine production that has been 
observed in most short-term studies until now, but the 
results corroborate those of the medium-term study of 
Cannon et al. [18]. Our findings emphasize the need for a 
well-controlled intervention trial comparing short-term 
and long-term effects of dietary fish oil supplementation.
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